相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study
Stamatina Iliodromiti et al.
HUMAN REPRODUCTION (2013)
Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG
Ayse Seyhan et al.
HUMAN REPRODUCTION (2013)
Management of Ovarian Hyperstimulation Syndrome. Produced on behalf of the BFS Policy and Practice Committee
Bee Kang Tan et al.
HUMAN FERTILITY (2013)
Retrieving oocytes from small non-stimulated follicles in polycystic ovary syndrome (PCOS): in vitro maturation (IVM) is not indicated in the new GnRH antagonist era
Dominique de Ziegler et al.
FERTILITY AND STERILITY (2012)
In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles
Anne-Sophie Gremeau et al.
FERTILITY AND STERILITY (2012)
Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women
Kannamannadiar Jayaprakasan et al.
FERTILITY AND STERILITY (2012)
Targeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSS
John Yovich et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives
Peter Humaidan et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?
Jyotsna Pundir et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis
Christos A. Venetis et al.
FERTILITY AND STERILITY (2011)
A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study
Evangelos G. Papanikolaou et al.
FERTILITY AND STERILITY (2011)
Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF
A. P. Yates et al.
HUMAN REPRODUCTION (2011)
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
P. Humaidan et al.
HUMAN REPRODUCTION UPDATE (2011)
The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation
Hossam Abdalla et al.
FERTILITY AND STERILITY (2010)
1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study
Peter Humaidan et al.
FERTILITY AND STERILITY (2010)
Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis
Mohamed A. F. M. Youssef et al.
HUMAN REPRODUCTION UPDATE (2010)
Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review
Panagiotis Peitsidis et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Ovarian Hyperstimulation Syndrome Prevention Strategies: Cryopreservation of All Embryos
Arianna D'Angelo
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization
Luciano G. Nardo et al.
FERTILITY AND STERILITY (2009)
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Scott M. Nelson et al.
HUMAN REPRODUCTION (2009)
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
Lawrence Engmann et al.
FERTILITY AND STERILITY (2008)
Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study
Carlos Carizza et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2008)
Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles
Tsung-Hsien Leeh et al.
HUMAN REPRODUCTION (2008)
Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment:: a pilot study
Claudio Alvarez et al.
HUMAN REPRODUCTION (2007)
Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction
Claudio Alvarez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles
Geeta Nargund et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2007)
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology
A. La Marca et al.
HUMAN REPRODUCTION (2007)
GnRH antagonists in ovarian stimulation for IVF
B. C. Tarlatzis et al.
HUMAN REPRODUCTION UPDATE (2006)
GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study
C. Pirard et al.
HUMAN REPRODUCTION (2006)
The use of metformin for women with PCOS undergoing IVF treatment
Thomas Tang et al.
HUMAN REPRODUCTION (2006)
Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment:: a prospective randomized trial
R Babayof et al.
HUMAN REPRODUCTION (2006)
Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer
Nicola Doldi et al.
GYNECOLOGICAL ENDOCRINOLOGY (2006)
Coasting for the prevention of ovarian hyperstimulation syndrome:: much ado about nothing?
JA García-Velasco et al.
FERTILITY AND STERILITY (2006)
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
EG Papanikolaou et al.
FERTILITY AND STERILITY (2006)
Complications of IVF and ovulation induction
R Klemetti et al.
HUMAN REPRODUCTION (2005)
Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome
R Mansour et al.
HUMAN REPRODUCTION (2005)
Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization
WJ Zhu et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2005)
Can we eliminate severe ovarian hyperstimulation syndrome?
R Orvieto
HUMAN REPRODUCTION (2005)
The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome
AJ Tozer et al.
HUMAN REPRODUCTION (2004)
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance
G Doronzo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients:: a randomized controlled study
J Bellver et al.
HUMAN REPRODUCTION (2003)
Unilateral follicular aspiration and in-vitro maturation before contralateral oocyte retrieval:: a method to prevent ovarian hyperstimulation syndrome
AK Schröder et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2003)
A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome
S Christin-Maitre et al.
HUMAN REPRODUCTION (2003)
Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception
R Mathur et al.
FERTILITY AND STERILITY (2002)
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review
A Delvigne et al.
HUMAN REPRODUCTION UPDATE (2002)
Edmbryo freezing for preventing ovarian hyperstimulation syndrome: a Cochrane review
A D'Angelo et al.
HUMAN REPRODUCTION (2002)
Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos
T Endo et al.
HUMAN REPRODUCTION (2002)
A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients
A Delvigne et al.
HUMAN REPRODUCTION UPDATE (2002)
Preventive attitude of physicians to avoid OHSS in IVF patients
A Delvigne et al.
HUMAN REPRODUCTION (2001)
Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology:: Results of a clinical trial comparing two doses of rhCG (Ovidrel®) to urinary hCG (Profasi®) for induction of final follicular maturation in in vitro fertilization-embryo transfer
P Chang et al.
FERTILITY AND STERILITY (2001)
A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins
R Marci et al.
FERTILITY AND STERILITY (2001)
Intravenous albumin versus hydroxyethyl starch for the prevention of ovarian hyperstimulation in an in-vitro fertilization programme: a prospective randomized placebo controlled study
O Gokmen et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2001)
Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome:: prospective, randomized comparison between low-dose step-up and modified step-down regimens
J Balasch et al.
HUMAN REPRODUCTION (2001)
Does laparoscopic ovarian diathermy affect the outcome of IVF-embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study
AJ Tozer et al.
HUMAN REPRODUCTION (2001)
Distinction between early and late ovarian hyperstimulation syndrome
RS Mathur et al.
FERTILITY AND STERILITY (2000)
分享论文
